Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cole Wayant

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
JAMA Oncology|September 6, 2019
Evaluation of Reproducible Research Practices in Oncology Systematic Reviews With Meta-analyses Referenced by National Comprehensive Cancer Network GuidelinesCole Wayant, Matthew J Page, Matt Vassar
BMJ Evidence-Based Medicine|February 6, 2020
Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugsWill Roberts, Samuel Jellison, Cole Wayant, et al.
Addictive Behaviors|November 27, 2019
Data sharing practices in randomized trials of addiction interventionsMatt Vassar, Sam Jellison, Hannah Wendelbo, et al.
Clinical Medicine & Research|February 6, 2021
STARD Adherence in an Interventional Radiology Guideline for Diagnostic ArteriographyBryan Wright, Benjamin Howard, Cole Wayant, et al.
JAMA Neurology|December 18, 2018
Association of Conflicts of Interest for Public Speakers for the Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration With Their StatementsWade Arthur, Jennifer Austin, Cole Wayant, et al.
BMJ Evidence-Based Medicine|March 25, 2019
Evaluation of the NCCN guidelines using the RIGHT Statement and AGREE-II instrument: a cross-sectional reviewCole Wayant, Craig Cooper, D'Arcy Turner, et al.
Journal of General Internal Medicine|July 15, 2020
Evaluation of Selective Outcome Reporting Bias in Efficacy Endpoints in Print and Television Advertisements for Oncology DrugsCole Wayant, Greg Aran, Bradley S Johnson, et al.
Journal of the Medical Library Association : JMLA|January 11, 2021
Citation bias in otolaryngology systematic reviewsMatt Vassar, Austin L Johnson, Adriana Sharp, et al.
Chest|November 10, 2020
The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee MeetingsTrevor Bickford, Nicholas Kinder, Wade Arthur, et al.
Chest|February 8, 2018
How Fragile Are Clinical Trial Outcomes That Support the CHEST Clinical Practice Guidelines for VTE?Elizabeth Edwards, Cole Wayant, Jonathan Besas, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
JAMA Oncology|September 6, 2019
Evaluation of Reproducible Research Practices in Oncology Systematic Reviews With Meta-analyses Referenced by National Comprehensive Cancer Network GuidelinesCole Wayant, Matthew J Page, Matt Vassar
BMJ Evidence-Based Medicine|February 6, 2020
Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugsWill Roberts, Samuel Jellison, Cole Wayant, et al.
Addictive Behaviors|November 27, 2019
Data sharing practices in randomized trials of addiction interventionsMatt Vassar, Sam Jellison, Hannah Wendelbo, et al.
Clinical Medicine & Research|February 6, 2021
STARD Adherence in an Interventional Radiology Guideline for Diagnostic ArteriographyBryan Wright, Benjamin Howard, Cole Wayant, et al.
JAMA Neurology|December 18, 2018
Association of Conflicts of Interest for Public Speakers for the Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration With Their StatementsWade Arthur, Jennifer Austin, Cole Wayant, et al.
BMJ Evidence-Based Medicine|March 25, 2019
Evaluation of the NCCN guidelines using the RIGHT Statement and AGREE-II instrument: a cross-sectional reviewCole Wayant, Craig Cooper, D'Arcy Turner, et al.
Journal of General Internal Medicine|July 15, 2020
Evaluation of Selective Outcome Reporting Bias in Efficacy Endpoints in Print and Television Advertisements for Oncology DrugsCole Wayant, Greg Aran, Bradley S Johnson, et al.
Journal of the Medical Library Association : JMLA|January 11, 2021
Citation bias in otolaryngology systematic reviewsMatt Vassar, Austin L Johnson, Adriana Sharp, et al.
Chest|November 10, 2020
The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee MeetingsTrevor Bickford, Nicholas Kinder, Wade Arthur, et al.
Chest|February 8, 2018
How Fragile Are Clinical Trial Outcomes That Support the CHEST Clinical Practice Guidelines for VTE?Elizabeth Edwards, Cole Wayant, Jonathan Besas, et al.
Pageof 7